The Q4 earnings report for Rigel Pharmaceuticals (NASDAQ:RIGL) was released on Tuesday, March 3, 2026 at 04:01 PM.
Here’s what investors need to know about the latest announcement.
Earnings
Rigel Pharmaceuticals missed estimated earnings by -10.4%, reporting an EPS of $1.12 versus an estimate of $1.25.
Revenue was up $12.21 million from the same period last year.
Earnings History Overview
During the previous …